These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37926530)

  • 1. A Diabetic Patient with Prolonged Hyperammonemia Due to Urinary Tract Infection Caused by Urease-producing Bacteria.
    Inoue S; Yasuda H; Yoshida K; Mori K; Ogawa K; Yokotsuka Y; Okamoto H
    Intern Med; 2024 Jul; 63(13):1945-1949. PubMed ID: 37926530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of hyperammonemia with obstructive urinary tract infection by urease-producing bacteria].
    Goda T; Watanabe K; Kobayashi J; Nagai Y; Ohara N; Takahashi D
    Rinsho Shinkeigaku; 2017 Mar; 57(3):130-133. PubMed ID: 28228622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of hyperammonemia resulting from urinary tract infection caused by urease-producing bacteria in a Parkinson's disease patient with drug-induced urinary retention].
    Yasunishi M; Koumura A; Hayashi Y; Nishida S; Inuzuka T
    Nihon Ronen Igakkai Zasshi; 2017; 54(4):560-566. PubMed ID: 29212999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple renal abscesses due to Proteus mirabilis.
    Kakuchi Y
    Clin Exp Nephrol; 2021 Mar; 25(3):322-323. PubMed ID: 33070221
    [No Abstract]   [Full Text] [Related]  

  • 5. [A Case of Hyperammonemia Caused by Urinary Tract Infection Due to Urease-Producing Bacteria].
    Emura M; Tsuchihashi K; Shimizu Y; Kanamaru S; Matoba S; Ito N
    Hinyokika Kiyo; 2016 Aug; 62(8):421-5. PubMed ID: 27624109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemic encephalopathy caused by urinary tract infection with urinary retention.
    Sato S; Yokota C; Toyoda K; Naganuma M; Minematsu K
    Eur J Intern Med; 2008 Dec; 19(8):e78-9. PubMed ID: 19046708
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of hyperammonemia caused by urinary tract infection due to urease-producing bacteria in dementia with Lewy bodies].
    Hashimoto S; Tamura Y; Kodera R; Tachibana A; Toyoshima K; Oba K; Toyoshima K; Nishina Y; Chiba Y; Araki A
    Nihon Ronen Igakkai Zasshi; 2021; 58(2):297-302. PubMed ID: 34039807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for Proteus mirabilis in urinary tract infection.
    Li X; Mobley HL
    Int J Antimicrob Agents; 2002 Jun; 19(6):461-5. PubMed ID: 12135833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis.
    Samtoy B; DeBeukelaer MM
    Pediatrics; 1980 Feb; 65(2):294-7. PubMed ID: 6444460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemagglutinin, urease, and hemolysin production by Proteus mirabilis from clinical sources.
    Mobley HL; Chippendale GR
    J Infect Dis; 1990 Mar; 161(3):525-30. PubMed ID: 2179424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperammonemia in hydronephrosis].
    van Daele PL; Quero Guillen JC; Lesterhuis W; Van Der Meulen J
    Ned Tijdschr Geneeskd; 1998 Oct; 142(44):2414-5. PubMed ID: 9864539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purple urine bag syndrome.
    Shaeriya F; Al Remawy R; Makhdoom A; Alghamdi A; M Shaheen FA
    Saudi J Kidney Dis Transpl; 2021; 32(2):530-531. PubMed ID: 35017348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urease-positive bacteriuria and obstruction of long-term urinary catheters.
    Mobley HL; Warren JW
    J Clin Microbiol; 1987 Nov; 25(11):2216-7. PubMed ID: 3320089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of liver cirrhosis with hyperammonemic encephalopathy caused by urease-producing bacteria in the urinary tract.
    Hashiguchi M; Tamai T; Kiyama K; Ooi T; Yamauchi T; Kamikihara Y; Kodama T; Kawahira M; Nakamura Y; Yano H; Nakazawa J; Iwashita Y; Nasu Y; Hori T; Tsubouchi H; Ido A
    Clin J Gastroenterol; 2021 Apr; 14(2):650-655. PubMed ID: 33400189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Urease Activity.
    Richmond S; Yep A
    Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection.
    Johnson DE; Russell RG; Lockatell CV; Zulty JC; Warren JW; Mobley HL
    Infect Immun; 1993 Jul; 61(7):2748-54. PubMed ID: 8514376
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Manoharan A; Farrell J; Aldilla VR; Whiteley G; Kriel E; Glasbey T; Kumar N; Moore KH; Manos J; Das T
    Front Cell Infect Microbiol; 2023; 13():1216798. PubMed ID: 37965267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From Catheter to Kidney Stone: The Uropathogenic Lifestyle of Proteus mirabilis.
    Norsworthy AN; Pearson MM
    Trends Microbiol; 2017 Apr; 25(4):304-315. PubMed ID: 28017513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Emphysematous pyelonephritis].
    Monllor Gisbert J; Galbis Palau F
    Arch Esp Urol; 1995 Nov; 48(9):956-9. PubMed ID: 8554404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control.
    Broomfield RJ; Morgan SD; Khan A; Stickler DJ
    J Med Microbiol; 2009 Oct; 58(Pt 10):1367-1375. PubMed ID: 19556373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.